Knowledge and Perception of Vaccine Pharmacovigilance and Adverse Events Following Immunization Reporting Among Pharmacy Students in India: An Online-Based Cross-Sectional Study Vishwa R. Byakod, Vijaysanti Deva, Omkar S. Pandare, Ramesh Bhandari, M.S. Ganachari Current Drug Safety, 2025 Background: In India, the knowledge and perception of vaccine pharmacovigilance and adverse events following immunization (AEFI) reporting among pharmacy students are not clear. Aim: This study aimed to evaluate the current knowledge and perceptions of vaccine pharmacovigilance and AEFI reporting among pharmacy students. Method: An online cross-sectional survey was conducted for three months. Validated structured questionnaires were circulated through emails and social media (Facebook and WhatsApp) to pharmacy students in India. Results: A total of 205 responses (response rate = 53.5%) were received, out of which 196 consented to participate, and the remaining nine refused to participate in the study. The average knowledge score was found to be 7.54±1.78. In our survey, 82.7% of participants did not report AEFI. Moreover, 50% of participants reported that vaccine pharmacovigilance is not yet covered in the syllabus, and 66.3% said they were not trained during their studies for AEFI reporting. Timely reporting of AEFI can help to identify safety issues with vaccines, which can lead to improvements in vaccine safety. It was found that 96.9% of participants had a perception that pharmacists should be involved in reporting AEFI, and 95.4% of participants were willing to undergo training on vaccine pharmacovigilance. Conclusion: The AEFI reporting system, primarily managed by pharmacists in India, highlights the need to include vaccine pharmacovigilance and AEFI reporting in the pharmacy curriculum. Continuous training programs are also essential to enhance knowledge and improve AEFI reporting practices.
Patient and healthcare professional perspective on challenges in lipid profile management in dyslipidemia patients: Two separate cross-sectional surveys Ramesh Bhandari, Madiwalayya Shivakantayya Ganachari Journal of Applied Pharmaceutical Science, 2024 Dyslipidemia is one of the major causes of cardiovascular ailments. Despite the fact patients with dyslipidemia continue to increase due to dependent on patient-related factors. To comprehensively explore patients’ knowledge, attitudes, and practices related to dyslipidemia, while also identifying challenges in lipid profile management among healthcare professionals. Two separate cross-sectional studies were conducted for 6 months (July–December 2021) in a tertiary care teaching hospital. The questionnaire (tool) for both surveys was prepared after a thorough review of the literature and then validated by a group of healthcare professionals. Eligible participants were enrolled after taking written informed consent. The current findings suggest poor knowledge, attitude, and practice of patients toward dyslipidemia and its management. Only 23.76% of healthcare professionals have attended seminars or continuing medical education on the management of dyslipidemia in the past year. It is surprising that only 37.62% of healthcare professionals surveyed know about the Lipid Association of India expert consensus statement on the management of dyslipidemia in Indians. Patient forgetfulness (66.37%) followed by the low education level of the patient (59.41%), side effects of the treatment (41.58%), high cost of the drugs (40.59%), and are the common reasons for noncompliance to the dyslipidemia therapy as reported by healthcare professionals. Patient-related factors contribute to major challenges in the management of dyslipidemia. The lack of awareness among healthcare professionals regarding dyslipidemia guidelines is attributed to the diversity in available guidelines and the limited applicability of Western-centric recommendations to Asian populations.
Steroid as a saviour and culprit in pemphigus vulgaris therapy: A rare case series Deepthi Avvaru, Raushan Kumar Chaudhary, Bhavana Doshi, Ramesh Bhandari Current Drug Therapy, 2024 Introduction: Pemphigus is a group of autoimmune dermatological life-threatening diseases of which Pemphigus Vulgaris (PV) is the most common (1-5 cases/million/year) with a mortality rate of 60-90%. PV is generally characterized by painful oral erosions, along with or without cutaneous lesions, as blisters are often misdiagnosed. The management strategy of PV includes steroids along with adjuvant therapy. Case Presentation: We report the case of three female patients with a mean age of 30.67 years who were diagnosed with pemphigus vulgaris and was on steroid therapy for a long duration. The longterm steroid therapy in all these three patients resulted in adverse drug reactions such as Cushing syndrome, oral and vaginal candidiasis. Although the steroid was found to cause ADR among these patients, the treatment with steroids and rituximab was continued. The withdrawal of steroids results in flare-up conditions, whereas the addition of rituximab serves as a steroid sparring partner in the management of PV. However, premedication was administered before the infusion of rituximab to prevent potential toxicity associated with rituximab. Further, administration of pulse therapy over oral dosing of steroids lowers the risks of ADR and long-term complications associated with steroids. Conclusion: As PV requires the management with high doses of steroids along with the immunosuppressant, patients are more prone to developing drug-related problems. Hence, the rigorous monitoring of the therapy is vital to prevent adverse effects of long-term therapy. Clinical pharmacists and pharmacologists are the most suitable pillar of the healthcare system for drug therapy management.
Pharmacists’ Medication Reconciliation Interventions During Admission and Transfer from an Emergency Department at a Tertiary Care Hospital: A Randomized Pilot Study and Evaluation of Physician and Patient Perceptions Ashitha George Joseph, Santra Saji, Anagha Nivrutti Kumbhar, Shivakumar G., Ramesh Bhandari, M. S. Ganachari Current Drug Safety, 2024 Aim: The study aimed to assess the impact of pharmacist interventions during the transition of care. Background: Medication discrepancies can occur at various levels of transition, such as during admission, the transition from emergency to special wards or from special to general wards, and during discharge. Discrepancies can be detected through the process of medication reconciliation. Objective: The objective of the study was to compare discrepancies among patients exposed to pharmacist intervention groups and those who were not and assess the perception of healthcare professionals and patients towards integrating pharmacists in the transition care process. Methods: A pharmacist-led interventional study was conducted for six months on patients above 18 years of age and either sex who were admitted to the emergency department, had chronic diseases, and subsequently transferred to another department (any). The patients were randomized into intervention and control groups. The pharmacist performed a medication reconciliation and medication review to identify discrepancies in every transition in both the groups, and then reported to the treating physician to resolve in the intervention group. Results: Among the 73 patients recruited in the study, 152 discrepancies were identified. The total discrepancies observed in the control and intervention groups were 78 (51.3%) and 74 (48.6%), respectively. The majority, 35.53%, were found during the transition from emergency to special wards. The physician, upon pharmacist recommendations, accepted and resolved 48 discrepancies in the intervention group. The healthcare professional acceptance rate of pharmacist interventions was 64.86%. Conclusion: The transitions of care are at risk for errors due to medication discrepancies, and pharmacists could potentially identify and resolve discrepancies. Healthcare professionals and patients reported to be satisfied by the involvement of clinical pharmacists in the healthcare team.
Clinical Pharmacist Led Approach on Enhancement of Medication Adherence Resolving the Drug Related Problems with Selective Serotonin Reuptake Inhibitors among the Patients with Psychiatric Illness. A Prospective, Pre and Post Non-Randomised Interventional Study Pratheeksha T John, Varsha Mariam John, K Gowtham, Ashish Singh Parihar, Ramesh Bhandari, M S Ganachari Indian Journal of Pharmaceutical Education and Research, 2023 Abstract: Introduction: Non-adherence is one of the most common barriers to the successful completion of treatment and it can be worst in psychiatric patients. Objectives: To assess, compare and resolve drug-related problems and medication adherence among psychiatric patients with SSRI and to assess the association between non-adherence and drug-related problems. Materials and Methods: In this prospective, non-randomized interventional study 90 psychiatry patients which were on SSRI treatment of both gender, aged more than 18 years were included. Written informed consent was obtained from the patient prior to enrol in the study. Results: Out of 90 patients enrolled, 51 (56.7%) patients reported DRPs and after pharmacist intervention, it was reduced to 26 (28.9%). Results showed a significant association between drug-related problems and medication adherence. Baseline and follow-up MARS scores are compared and found that there is a significant increase in the adherence score of patients after pharmacist intervention. Conclusion: This study results show that through proper patient education it is possible to improve medication adherence and to optimize medication use, which may reduce the DRPs. It will help eventually help to decrease drug-related morbidity and mortality. Keywords: Medication adherence, Drug Related Problems, SSRI, Mood disorders, MARS.
Corn Silk (Stigma maydis) Use in Diabetes: Molecular, Cellular, and Metabolic Effects Ramesh Bhandari, Raushan Kumar Chaudhary, Pukar Khanal, Madiwalayya S. Ganachari Ancient and Traditional Foods Plants Herbs and Spices Used in Diabetes, 2023 Isolated compounds and extracts from various medicinal plants were studied for their potential use in diabetes therapy. Corn is also known as maize, and its seeds are edible in most Asian countries. Corn silk is a long, pigmented (yellowish to reddish) hair-like structure covering the edible portion of corn. This review focuses on the molecular, cellular, and metabolic effects of corn silk (Stigma maydis) in the treatment of diabetes. The antidiabetic effect of corn silk is due to the potential candidates such as the presence of flavonoids, phenolic acids, phytosterols, carotenoids, and tannins. We discuss the effect of corn silk on cellular and molecular pathways involved in preventing and treating diabetes. Further, we cover corn silk’s toxicity and summarize other plants or parts used in diabetes treatment.
Isoniazid induced psychosis Journal of Global Pharma Technology, 2019
Brown, white and blue bagging in special pharmacy: An emerging trend to minimize medication error Journal of Global Pharma Technology, 2019
The linkage between occupation and stress among community health workers: An indo-global perspective Biomedicine India, 2019
RECENT SCHOLAR PUBLICATIONS
Health Related Quality of Life and its Predictors among Dyslipidemia Patients: A Cross-Sectional Study. R Bhandari, MS Ganachari International Journal of Pharmaceutical Investigation 15 (3) , 2025 2025
ISPOR REPORT RH Henderson, C Sampson, XGLV Pouwels, S Harvard, R Handels, ... 2025
Mapping the landscape of open source health economic models: a systematic database review and analysis: an ISPOR special interest group report RH Henderson, C Sampson, XGLV Pouwels, S Harvard, R Handels, ... Value in Health 28 (6), 813-820 , 2025 2025 Citations: 6
Knowledge and Perception of Vaccine Pharmacovigilance and Adverse Events Following Immunization Reporting Among Pharmacy Students in India: An Online-Based Cross-Sectional Study. VR Byakod, V Deva, OS Pandare, R Bhandari, MS Ganachari Current Drug Safety , 2025 2025
Cardiovascular disease and disability R Bhandari, MS Ganachari The Palgrave Encyclopedia of Disability, 1-9 , 2025 2025 Citations: 3
CO77 Impact of Pharmacist Interventions on Drug Related Problems Among Geriatric Patient's in Tertiary Care Teaching Hospital R Bhandari, SU Revankar, M Ganachari Value in Health 27 (12), S29 , 2024 2024
Patient and healthcare professional perspective on challenges in lipid profile management in dyslipidemia patients: Two separate cross-sectional surveys R Bhandari, MS Ganachari Journal of Applied Pharmaceutical Science 14 (12), 180-186 , 2024 2024 Citations: 1
Analyzing Lessons from Previous COVID-19 Outbreaks for Future Preparedness: A Cross-Sectional Study. MS Reddy, AM Ganachari, R Bhandari, BY Raja, K Amaresh Journal of Young Pharmacists 16 (4) , 2024 2024
Retrospective analysis of Sliding Scale versus Basal Bolus Insulin in the treatment of uncontrolled hyperglycemia in patients with Type 2 diabetes mellitus and infections M Sanjeevani, M Alex, DP Sreedharan, BC Vinay, PS Supriya, ... International Journal of Diabetes in Developing Countries, 1-9 , 2024 2024
Pharmacists’ Medication Reconciliation Interventions During Admission and Transfer from an Emergency Department at a Tertiary Care Hospital: A Randomized Pilot Study and … AG Joseph, S Saji, AN Kumbhar, S G, R Bhandari, MS Ganachari Current Drug Safety 19 (3), 368-376 , 2024 2024 Citations: 3
Steroid as a Saviour and Culprit in Pemphigus Vulgaris Therapy: A Rare Case Series D Avvaru, RK Chaudhary, B Doshi, R Bhandari Current Drug Therapy 19 (3), 360-366 , 2024 2024
Optimizing oral anticoagulation therapy: impact of pharmacists intervention in patient knowledge and international normalized ratio (INR) control A Thomas, AH Ruby, S Mendgule, A Deshpande, S Patted, A Hiremath, ... Journal of Young Pharmacists 16 (2), 328 , 2024 2024 Citations: 1
Assessment of medication discrepancy, medication appropriateness, and cost analysis among patients with pediatric nephrotic syndrome: An ambispective cohort observational study D Avvaru, MS Reddy, S Azar, S Wali, MV Patil, R Bhandari, MS Ganachari Archives de Pédiatrie 31 (2), 106-111 , 2024 2024
Impact of educational awareness on knowledge and attitude of ADR reporting among medical, pharmacy, dentistry and nursing students: An interventional study TA Shamsher, S Khurpe, S Naikmani, R Bhandari, M Ganachari PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 32, 495-496 , 2023 2023
Corn silk (Stigma maydis) use in diabetes: molecular, cellular, and metabolic effects R Bhandari, RK Chaudhary, P Khanal, MS Ganachari Ancient and Traditional Foods, Plants, Herbs and Spices used in Diabetes … , 2023 2023 Citations: 2
Impact of Educational Intervention on Knowledge and Attitude Toward Pharmaceutical Care and Identification of Barriers Among Undergraduate Pharmacy Students R Bhandari, NM Jamkhandi, MS Ganachari The Global Health Network Collections , 2023 2023 Citations: 2
Clinical Pharmacist Led Approach on Enhancement of Medication Adherence Resolving the Drug Related Problems with Selective Serotonin Reuptake Inhibitors among the Patients with … PT John, VM John, K Gowtham, AS Parihar, R Bhandari, MS Ganachari Indian Journal of Pharmaceutical Education & Research 57 (2) , 2023 2023
Perceptions and challenges among health care providers about HIV-TB co-infected children-A qualitative study S Shrestha, M Angolkar, A Narasannavar, N Al-Aghbari, AK Ritti, ... Indian Journal of Tuberculosis 70, S82-S88 , 2023 2023 Citations: 2
Discrepancies occurred during multiple care transition process and their predictors in a tertiary care teaching hospital–a prospective observational study YR Tiwari, S Parghi, S Roychowdhury, R Bhandari, MS Ganachari Le Pharmacien Clinicien 57 (4), 309-316 , 2022 2022
A Randomized, Single Centered, Parallel and Open Labelled Interventional Study on Effectiveness of Clinical Pharmacists on Adverse Event Following Immunization (AEFI) in … RK Arvind, FA Beerwala, SC Wali, AS Parihar, MS Ganachari, R Bhandari Current Drug Safety 17 (4), 357-365 , 2022 2022
MOST CITED SCHOLAR PUBLICATIONS
Poor and unsatisfactory disposal of expired and unused pharmaceuticals: a global issue S Nepal, A Giri, R Bhandari, S Chand, S Nepal, S Aryal, P Khanal, ... Current drug safety 15 (3), 167-172 , 2020 2020 Citations: 57
Doctor of pharmacy: boon for healthcare system L Voora, SK Sah, R Bhandari, CS Shastry, S Chand, KB Rawal, ... Drug Invent Today 14 (1), 153-158 , 2020 2020 Citations: 51
Anti-diabetic potential of Corn silk ( Stigma maydis ): An in-silico approach RK Chaudhary, SS Karoli, PSR Dwivedi, R Bhandari Journal of Diabetes & Metabolic Disorders 21 (1), 445-454 , 2022 2022 Citations: 38
Health economics and effectiveness analysis of generic anti-diabetic medication from jan aushadhi: An ambispective study in community pharmacy RK Chaudhary, MJ Philip, A Santhosh, SS Karoli, R Bhandari, ... Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (6), 102303 , 2021 2021 Citations: 27
Brown, White and Blue Bagging in Special Pharmacy: An Emerging Trend to Minimize Medication Error RKB Sharad Chand, Shastry CS, Vinay BC, Bhandari Ramesh*, Kumar Sah Sujit Journal of Global Pharma Technology 11 (8), 01-04 , 2019 2019 Citations: 15
Impact of clinical pharmacist on medication adherence among psoriasis patients: A randomized controlled study AC Hiremath, R Bhandari, S Wali, MS Ganachari, B Doshi Clinical Epidemiology and Global Health 10, 100687 , 2021 2021 Citations: 12
Phenytoin-Induced Erythroderma SC Lavanya Voora, C.S Shastry, Ramesh Bhandari, Degam Sukeerthi, Kala ... Journal of Young Pharmacists 11 (3), 320-321 , 2019 2019 Citations: 12
Isoniazid induced psychosis S Chand, R Bhandari, HN Girish, D Sukeerthi, SK Sah, L Voora Journal of global pharma technology 11 (5), 11-14 , 2019 2019 Citations: 11
Outdated and unused medicines disposal practice among the undergraduate paramedical students–a pharmacist's intervention S Nepal, A Giri, CS Shastry, S Chand, S Aryal, P Khanal, R Bhandari Le Pharmacien Hospitalier et Clinicien 55 (4), 327-333 , 2020 2020 Citations: 10
Mapping the landscape of open source health economic models: a systematic database review and analysis: an ISPOR special interest group report RH Henderson, C Sampson, XGLV Pouwels, S Harvard, R Handels, ... Value in Health 28 (6), 813-820 , 2025 2025 Citations: 6
Evaluation of antiepileptic medication adherence among paediatric epileptic patients: a randomized prospective study in a teaching hospital. S WALI, N MAHANTSHETTI, MS Ganachari, R BHANDARI International Journal of Pharmaceutical Research (09752366) , 2020 2020 Citations: 4
Cardiovascular disease and disability R Bhandari, MS Ganachari The Palgrave Encyclopedia of Disability, 1-9 , 2025 2025 Citations: 3
Pharmacists’ Medication Reconciliation Interventions During Admission and Transfer from an Emergency Department at a Tertiary Care Hospital: A Randomized Pilot Study and … AG Joseph, S Saji, AN Kumbhar, S G, R Bhandari, MS Ganachari Current Drug Safety 19 (3), 368-376 , 2024 2024 Citations: 3
Fixed drug eruptions secondary to fixed drug combination (ofloxacin/ornidazole): a cross sensitivity case report RK Chaudhary, AR Metgudmath, R Bhandari, SS Karoli, UK R Current Drug Therapy 16 (5), 448-453 , 2021 2021 Citations: 3
Clinical pharmacist approach towards effectiveness of pulmonary rehabilitation of the patient with COPD: a randomized controlled study M Vastrad, S Wall, MS Ganachari Indian J Pharm Educ Res 55 (1), s318-s324 , 2021 2021 Citations: 3
Beta Thalessemia Major; Rare Haematological Disorder R Bhandari, S Chand, V Lal J Pharm Pharm Sci 7 (5), 1442-1445 , 2018 2018 Citations: 3
Corn silk (Stigma maydis) use in diabetes: molecular, cellular, and metabolic effects R Bhandari, RK Chaudhary, P Khanal, MS Ganachari Ancient and Traditional Foods, Plants, Herbs and Spices used in Diabetes … , 2023 2023 Citations: 2
Impact of Educational Intervention on Knowledge and Attitude Toward Pharmaceutical Care and Identification of Barriers Among Undergraduate Pharmacy Students R Bhandari, NM Jamkhandi, MS Ganachari The Global Health Network Collections , 2023 2023 Citations: 2
Perceptions and challenges among health care providers about HIV-TB co-infected children-A qualitative study S Shrestha, M Angolkar, A Narasannavar, N Al-Aghbari, AK Ritti, ... Indian Journal of Tuberculosis 70, S82-S88 , 2023 2023 Citations: 2
A study on knowledge and practice of dispensing drugs without prescription by pharmacists in Belagavi City S Sharma, S Patil, A Narasannavar, R Bhandari Journal of the Scientific Society 48 (3), 197-202 , 2021 2021 Citations: 2